GEA Procomac’s aseptic filling technology

Published: 14-Apr-2008

The Food & Drug Administration (FDA) has issued a letter of non-objection that allows US specialist GEA Procomac to install new aseptic filling technology.


GEA Procomac, which is part of US engineering company GEA Group, received the letter for aseptic filling systems used in low acid shelf-stable products.

The letter was granted after an FDA review of a master file submission based on Procomac’s aseptic line installation at Aseptic Solutions Inc., a company based in Corona, CA. The National Food Laboratory (The NFL) served as Procomac’s Process Authority for the master filing.

Procomac FDA-compliant aseptic filling technology for PET uses peracetic acid in liquid form to sterilise containers. Full recovery of sterilising solution and rinsing water is built in the system to reduce consumption of chemicals.

Procomac has pioneered a number of aseptic technologies in the past ten years, including the use of a microbiological isolator technology instead of the traditional clean room environment for aseptic filling lines.

Procomac has installed 86 aseptic filling lines; 30 of them are capable of running low acid products and 6 of these lines have been built to FDA standards in the US.

You may also like